دورية أكاديمية

Salvianolic acid A alleviates H 2 O 2 -induced endothelial oxidative injury via miR-204-5p.

التفاصيل البيبلوغرافية
العنوان: Salvianolic acid A alleviates H 2 O 2 -induced endothelial oxidative injury via miR-204-5p.
المؤلفون: Qiao X; School of Life Science, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China., Cao S; School of Life Science, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China., Chen S; School of Life Science, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China., Guo Y; Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China., Chen N; School of Life Science, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China., Zheng Y; The 903rd Hospital of the People's Liberation Army, Hangzhou, Zhejiang, China. zhengying72@163.com., Jin B; School of Life Science, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China. jinbo@zcmu.edu.cn.
المصدر: Scientific reports [Sci Rep] 2024 May 24; Vol. 14 (1), pp. 11931. Date of Electronic Publication: 2024 May 24.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE
أسماء مطبوعة: Original Publication: London : Nature Publishing Group, copyright 2011-
مواضيع طبية MeSH: MicroRNAs*/genetics , MicroRNAs*/metabolism , Hydrogen Peroxide*/toxicity , Hydrogen Peroxide*/pharmacology , Human Umbilical Vein Endothelial Cells*/drug effects , Human Umbilical Vein Endothelial Cells*/metabolism , Oxidative Stress*/drug effects , Lactates*/pharmacology , Lactates*/metabolism , Apoptosis*/drug effects , Cell Survival*/drug effects, Humans ; Caffeic Acids/pharmacology ; Cell Proliferation/drug effects ; Reactive Oxygen Species/metabolism ; Autophagy/drug effects ; Cellular Senescence/drug effects ; Antioxidants/pharmacology ; NLR Family, Pyrin Domain-Containing 3 Protein/metabolism ; NLR Family, Pyrin Domain-Containing 3 Protein/genetics
مستخلص: Oxidative stress induced endothelial dysfunction plays a particularly important role in promoting the development of cardiovascular diseases (CVDs). Salvianolic acid A (SalA) is a water-soluble component of traditional Chinese medicine Salvia miltiorrhiza Bunge with anti-oxidant potency. This study aims to explore the regulatory effect of SalA on oxidative injury using an in vitro model of H 2 O 2 -induced injury in human umbilical vein endothelial cells (HUVECs). In the study, we determined cell viability, the activities of Lactate dehydrogenase (LDH) and Superoxide dismutase (SOD), cell proliferation rate and intracellular reactive oxygen species (ROS). Flow cytometry was used to detect cell apoptosis. Western-blotting was used to evaluate the expression of cell senescence, apoptosis, autophagy and pyroptosis protein factors. The expression level of miRNA was determined by qRT-PCR. Compared with H 2 O 2 -induced HUVECs, SalA promoted cell viability and cell proliferation rate; decreased LDH and ROS levels; and increased SOD activity. SalA also significantly attenuated endothelial senescence, inhibited cell apoptosis, reversed the increase of LC3 II/I ratio and NLRP3 accumulation. Furthermore, miR-204-5p was regulated by SalA. Importantly, miR-204-5p inhibitor had similar effect to that of SalA on H 2 O 2 -induced HUVECs. Our results indicated that SalA could alleviate H 2 O 2 -induced oxidative injury by downregulating miR-204-5p in HUVECs.
(© 2024. The Author(s).)
References: Front Immunol. 2019 Nov 28;10:2795. (PMID: 31849973)
Chin J Integr Med. 2019 Jan;25(1):23-30. (PMID: 28197936)
Arch Biochem Biophys. 2022 Jan 15;715:109098. (PMID: 34856194)
Stem Cell Res Ther. 2021 Jan 18;12(1):64. (PMID: 33461605)
Int J Mol Sci. 2023 Oct 13;24(20):. (PMID: 37894840)
Biomedicines. 2022 Apr 27;10(5):. (PMID: 35625746)
J Cell Physiol. 2020 Dec;235(12):9851-9863. (PMID: 32452584)
Brain Res. 2017 Feb 15;1657:279-287. (PMID: 28011395)
Nat Rev Cardiol. 2019 Apr;16(4):203-212. (PMID: 30467329)
J Mol Cell Cardiol. 2019 Nov;136:27-41. (PMID: 31505198)
Mol Med Rep. 2020 Oct;22(4):2645-2654. (PMID: 32945425)
Front Immunol. 2024 Mar 07;15:1359600. (PMID: 38515749)
Mol Med Rep. 2018 Nov;18(5):4163-4174. (PMID: 30221706)
Biomed Pharmacother. 2019 Mar;111:151-161. (PMID: 30579254)
Pharmacol Rev. 2021 Jul;73(3):924-967. (PMID: 34088867)
Pharmacol Res. 2022 Apr;178:106143. (PMID: 35219871)
J Mol Endocrinol. 2019 Aug;63(2):139-149. (PMID: 31277072)
Asian J Surg. 2017 Sep;40(5):396-406. (PMID: 27519795)
Korean J Physiol Pharmacol. 2020 Nov 1;24(6):473-479. (PMID: 33093269)
Cells. 2023 Nov 21;12(23):. (PMID: 38067099)
Oxid Med Cell Longev. 2019 Mar 18;2019:2853534. (PMID: 31011401)
Sci Rep. 2017 Aug 24;7(1):9308. (PMID: 28839162)
Front Cell Dev Biol. 2021 Sep 14;9:702974. (PMID: 34595164)
Bioengineered. 2022 Apr;13(4):11072-11081. (PMID: 35481411)
Biomed Pharmacother. 2019 Feb;110:9-19. (PMID: 30453254)
Nutrients. 2019 Nov 15;11(11):. (PMID: 31731808)
J Ethnopharmacol. 2023 Dec 5;317:116772. (PMID: 37400004)
Cold Spring Harb Perspect Med. 2016 Apr 01;6(4):a026120. (PMID: 27037419)
Oncotarget. 2016 Oct 25;7(43):70058-70065. (PMID: 27588402)
J Cardiovasc Dev Dis. 2022 Apr 27;9(5):. (PMID: 35621847)
Phytomedicine. 2021 Mar;83:153480. (PMID: 33548866)
IET Nanobiotechnol. 2020 Apr;14(2):155-160. (PMID: 32433033)
Cancer Med. 2023 Feb;12(3):3185-3200. (PMID: 35908280)
Onco Targets Ther. 2019 Dec 10;12:10787-10797. (PMID: 31849486)
Int J Mol Sci. 2019 Dec 12;20(24):. (PMID: 31842349)
Cell Death Dis. 2020 Sep 18;11(9):776. (PMID: 32948742)
Signal Transduct Target Ther. 2023 Mar 1;8(1):92. (PMID: 36859359)
Cell Death Discov. 2022 May 4;8(1):245. (PMID: 35508613)
Oxid Med Cell Longev. 2022 Jun 24;2022:4201287. (PMID: 35783188)
In Vitro Cell Dev Biol Anim. 2022 Aug;58(7):558-570. (PMID: 35947289)
Phytomedicine. 2023 Aug;117:154897. (PMID: 37307738)
Oxid Med Cell Longev. 2021 Jul 1;2021:7501424. (PMID: 34306314)
معلومات مُعتمدة: No.82304763 the Natural Science Foundation of China; No.82374071 the Natural Science Foundation of China; LY23H280006 the Natural Science Foundation of Zhejiang Province; 2022GJYY024 the Scientific Research Foundation of Zhejiang Chinese Medical University
المشرفين على المادة: 0 (MicroRNAs)
BBX060AN9V (Hydrogen Peroxide)
51622542XO (salvianolic acid A)
0 (Lactates)
0 (Caffeic Acids)
0 (Reactive Oxygen Species)
0 (Antioxidants)
0 (NLR Family, Pyrin Domain-Containing 3 Protein)
تواريخ الأحداث: Date Created: 20240524 Date Completed: 20240524 Latest Revision: 20240611
رمز التحديث: 20240612
مُعرف محوري في PubMed: PMC11126572
DOI: 10.1038/s41598-024-62556-4
PMID: 38789509
قاعدة البيانات: MEDLINE
الوصف
تدمد:2045-2322
DOI:10.1038/s41598-024-62556-4